Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Sometimes the right move isn't the popular choice.

Could a Dividend Cut Actually Make Sense for This Dividend King?

The FDA in June ordered Juul's products off the U.S. market, although the decision has been suspended pending an appeal.

Juul Said to Be Looking at Financing Options for a Potential Bankruptcy

Altria's dividend yield may sound too good to be true, but investors should take a closer look at its financials and business.

Is Altria's 9% Monster Dividend Yield Safe?

Enterprise Products Partners

Innovative Industrial Properties

These supercharged income stocks, with yields ranging from 8% to 9.3%, are ripe for the picking by opportunistic investors.

3 Ultra-High-Yield Dividend Stocks Begging to Be Bought in October

Pfizer

V.F.

Viatris

Verizon

The silver lining amid the market collapse is that every new dollar put to work today in dividend stocks comes with an automatic higher yield when compared to just a few weeks ago. First up, I'm thinking about adding to recent spin-off Viatris Inc.

October 2022 Stock Considerations

Best Buy

Barclays

Ford Motor Company

GlaxoSmithKline

Intel

Iron Mountain

With recent stock market weakness, look for long-term dividend stocks to buy. After failing to hold a rally that began in June 2022, the S&P 500 erased more than it gained by Sept.

This Is the Best Time to Buy These 7 Long-Term Dividend Stocks

Is the tobacco giant's 9% dividend yield too good to be true?

Is Altria Stock a Value or a Value Trap?

Altria Group Inc. said Friday it has taken a step that extricates it from its noncompete arrangement with vaping company Juul Labs Inc., freeing both companies to pursue their own strategies.

Altria and Juul end noncompete deal: Here's what that means for e-cigarette sales and marketing

The maker of Marlboro cigarettes will now have the opportunity to start up its own vaping brand.

Altria to Invest in Rival Vaping Products. Ends Noncompete Agreement With Juul.

Altria Group Inc. MO, -0.58% said Friday it has exercised an option to be released from non-competition obligations relating to its stake in Juul Labs Inc. In a regulatory filing, the tobacco company said the option included the right to terminate should the carrying value of its investment in Juul be not more than 10% of its initial carrying value of $12.8 billion. As of June 30, the carrying value had fallen to $450 million.

Altria ends non-compete agreement with troubled vaping company Juul Labs

Franklin Resources

Flowers Foods

Gaming and Leisure Properties

Huntington Bancshares

Kinder Morgan

LyondellBasell Industries

M.D.C. Holdings

Medical Properties Trust

NortonLifeLock

National Retail Properties

Rent-A-Center

Sturm, Ruger & Company

Retail Opportunity Investments

Rayonier

Vale S.A.

Williams

Last year, May-August 2021, Kiplinger-Today listed eight sets of stocks sorted as: best-buys for 2021, infrastructure-plays, value, growth, small-cap, high-yield, housing-bets, and cash-flow-gushers. Those eight "exceptional-dividend" articles revealed 86-equities, 76-paying-dividends. Kiplinger article-titles were, '21 Best Stocks to Buy'; '14 Best Infrastructure Stocks'; '16 Best Value; '10 Dividends-Growth'; '6 Small-Cap'; '10 High-Yield 4% or More;' '12 Housing; '10 Cash-Flow-Gushers.'

Buy 19 September 2021 Exceptional Dividend Dogs Now

Philip Morris

Altria and Philip Morris are two of the largest and most successful cigarette companies in the world. The main product line for both companies is smokable products which have had steadily decreasing unit sales every year for several years.

Altria Vs. Philip Morris: Which Is The Better Dividend Stock?

Enbridge

2022 is a crazy year with bond yields falling or flying like crypto and currencies like the Yen and British Pound acting like emerging market stocks. In crazy markets that make no sense, being able to rely purely on fundamentals and safe dividends for your retirement is truly priceless peace of mind.

2 High-Yield Dividend Aristocrats I'm Buying Now And So Should You

Apple

AstraZeneca

Costco

Chevron

Lockheed Martin

AT&T

There are several large-cap stocks with dividend growth potential even as broad market conditions remain challenging. In general, large-cap stocks are ignored by investors in a bull market.

7 Large-Cap Stocks With Sustained Dividend Growth Potential

British American Tobacco

“How to fight the Fed” has become a FAQ for us these days. We feel quite presumptuous for us to even attempt to answer this question. What individual investors can do in the face of macroeconomic forces are truly limited. Plus, the Fed itself probably does not know what its next move will be.

Altria And British American Tobacco: Take The Dividends, Stay Out Of The Fed's Way

Assertio Therapeutics Inc

iShares Nasdaq Biotechnology ETF

Magellan Midstream Partners

Rio Tinto plc Sponsored

Tyson Foods

Vanguard Value ETF

These are seven of the best stocks to buy that can see substantial returns in the months ahead. Despite the ongoing worries on Wall Street, seasoned investors realize that there may be a bull market in some segments of the market even during these gloomy weeks.

The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market

With cigarette usage losing steam and alternatives like vaping popular, Altria is charting a new course to get financially healthy.

MO Money: Why Altria Group Stock is Rallying

BHP Billiton

Newmont Mining

The year 2022 has been challenging for many investors. Making money seems complicated when inflation is high, and returns in several asset classes remain negative.

4 Deeply Undervalued Dividend Stocks With Yields Over 5%

Campbell Soup

PepsiCo

With the Federal Reserve continuing its hawkish trajectory, investors could benefit from deploying a defense-heavy approach with these three low-beta stocks.

Find Sunshine in a Dark Fiscal Overcast With These 3 Stocks

Juul is suing the U.S. Food and Drug Administration for refusing to disclose scientific documents that were central to banning the e-cigarette product.

Juul sues FDA for not disclosing documents justifying e-cigarette ban

Devon Energy

Could now be a good time to invest in these high yield dividend stocks amid the FOMC meeting?

4 High Dividend Yield Stocks Watch Amid The FOMC Meeting

In this article, I start by making the fundamental case for high-yield stocks given the risks of slower economic growth, persistent inflation, and aggressive central banks. Buying (very) high yield comes with risks, which is why buying quality is so important.

One Big Fat Reason To Buy Altria In Light Of Economic Woes

MGM Resorts

These beaten-down income stocks are primed to shine in these troubled times.

My 2 Top Dividend Stocks for September

News for Altria Stock (MO)